May 13, 2019
Celgene’s Pomalyst gets breakthrough therapy amrk from FDA for HIV-Positive and Negative Kaposi Sarcoma
Celgene plans additional studies with the AIDS Malignancy Consortiumin U.S. and sub-Saharan Africa
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Pomalyst